PortfoliosLab logoPortfoliosLab logo
CELC vs. CAPR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

CELC vs. CAPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Celcuity Inc. (CELC) and Capricor Therapeutics, Inc. (CAPR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, CELC achieves a -10.82% return, which is significantly lower than CAPR's -4.23% return.


CELC

1D
-2.70%
1M
-38.65%
YTD
-10.82%
6M
-11.05%
1Y
644.97%
3Y*
100.35%
5Y*
27.03%
10Y*

CAPR

1D
1.10%
1M
-17.49%
YTD
-4.23%
6M
-7.74%
1Y
147.89%
3Y*
82.46%
5Y*
48.25%
10Y*
-1.55%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CELC vs. CAPR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CELC
Celcuity Inc.
-10.82%661.96%-10.16%4.00%6.22%44.00%-13.91%-55.65%26.60%32.61%
CAPR
Capricor Therapeutics, Inc.
-4.23%109.13%182.21%26.68%31.74%-14.58%167.97%-68.78%-74.05%-22.17%

Correlation

The correlation between CELC and CAPR is 0.14, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.14

Correlation (3Y)
Calculated over the trailing 3-year period

0.23

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Sep 21, 2017

0.18

The correlation between CELC and CAPR shifts across timeframes, from 0.14 (1 year) to 0.26 (5 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

CELC:

$4.84B

CAPR:

$1.59B

EPS

CELC:

-$3.95

CAPR:

-$2.32

PB Ratio

CELC:

90.51

CAPR:

0.01

Total Revenue (TTM)

CELC:

$0.00

CAPR:

$0.00

Gross Profit (TTM)

CELC:

-$41.00K

CAPR:

-$42.41M

EBITDA (TTM)

CELC:

-$168.13M

CAPR:

-$117.24M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CELC vs. CAPR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CELC
CELC Risk / Return Rank: 9898
Overall Rank
CELC Sharpe Ratio Rank: 9696
Sharpe Ratio Rank
CELC Sortino Ratio Rank: 9999
Sortino Ratio Rank
CELC Omega Ratio Rank: 9999
Omega Ratio Rank
CELC Calmar Ratio Rank: 9999
Calmar Ratio Rank
CELC Martin Ratio Rank: 100100
Martin Ratio Rank

CAPR
CAPR Risk / Return Rank: 7979
Overall Rank
CAPR Sharpe Ratio Rank: 5454
Sharpe Ratio Rank
CAPR Sortino Ratio Rank: 9797
Sortino Ratio Rank
CAPR Omega Ratio Rank: 9797
Omega Ratio Rank
CAPR Calmar Ratio Rank: 7676
Calmar Ratio Rank
CAPR Martin Ratio Rank: 7171
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CELC vs. CAPR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Celcuity Inc. (CELC) and Capricor Therapeutics, Inc. (CAPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CELCCAPRDifference
Sharpe ratioReturn per unit of total volatility

+3.18

Sortino ratioReturn per unit of downside risk

+1.82

Omega ratioGain probability vs. loss probability

1.93

1.66

+0.27

Calmar ratioReturn relative to maximum drawdown

16.84

2.20

+14.65

Martin ratioReturn relative to average drawdown

74.95

4.14

+70.81

CELC vs. CAPR - Sharpe Ratio Comparison

The current CELC Sharpe Ratio is 3.57, which is higher than the CAPR Sharpe Ratio of 0.39. The chart below compares the historical Sharpe Ratios of CELC and CAPR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CELCCAPRDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

3.57

0.39

+3.18

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.27

0.26

+0.01

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

-0.01

Sharpe Ratio (All Time)

Calculated using the full available price history

0.26

-0.08

+0.34

Drawdowns

CELC vs. CAPR - Drawdown Comparison

The maximum CELC drawdown since its inception was -85.64%, smaller than the maximum CAPR drawdown of -99.97%. Use the drawdown chart below to compare losses from any high point for CELC and CAPR.


Loading charts...

Drawdown Indicators


CELCCAPRDifference

Max Drawdown

Largest peak-to-trough decline

-85.64%

-99.97%

+14.33%

Max Drawdown (1Y)

Largest decline over 1 year

-38.65%

-67.67%

+29.02%

Max Drawdown (3Y)

Largest decline over 3 years

-61.99%

-79.08%

+17.09%

Max Drawdown (5Y)

Largest decline over 5 years

-82.70%

-79.08%

-3.62%

Max Drawdown (10Y)

Largest decline over 10 years

-98.02%

Current Drawdown

Current decline from peak

-38.65%

-99.15%

+60.50%

Average Drawdown

Average peak-to-trough decline

-45.01%

-90.24%

+45.23%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.67%

35.87%

-27.20%

Volatility

CELC vs. CAPR - Volatility Comparison

Celcuity Inc. (CELC) has a higher volatility of 33.38% compared to Capricor Therapeutics, Inc. (CAPR) at 18.51%. This indicates that CELC's price experiences larger fluctuations and is considered to be riskier than CAPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CELCCAPRDifference

Volatility (1M)

Calculated over the trailing 1-month period

33.38%

18.51%

+14.87%

Volatility (6M)

Calculated over the trailing 6-month period

49.34%

163.76%

-114.42%

Volatility (1Y)

Calculated over the trailing 1-year period

182.52%

384.80%

-202.28%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

101.47%

190.11%

-88.64%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

91.64%

179.88%

-88.24%

Dividends

CELC vs. CAPR - Dividend Comparison

Neither CELC nor CAPR has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

CELC vs. CAPR - Financials Comparison

This section allows you to compare key financial metrics between Celcuity Inc. and Capricor Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.002.00M4.00M6.00M8.00M10.00M12.00M2022202320242025202600
(CELC) Total Revenue
(CAPR) Total Revenue
Values in USD except per share items

Frequently Asked Questions


CELC and CAPR have a correlation of 0.14, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

CELC has higher volatility (33.38%) compared to CAPR (18.51%). In terms of maximum drawdown, CELC dropped -85.64% vs CAPR's -99.97%.

CELC currently has the higher Sharpe Ratio (3.57 vs 0.39), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for CELC and CAPR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer